Associate Professor

Lisa Kaminskas

Email: 
Phone: 
+61 7 336 53124

Availability

Associate Professor Lisa Kaminskas is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, University of Adelaide

Search Professor Lisa Kaminskas’s works on UQ eSpace

97 works between 2000 and 2024
All (97) Journal Article (92) Book Chapter (3) Conference Publication (2)

81 - 97 of 97 works

2011

Journal Article

New developments in dry powder pulmonary vaccine delivery

Sou, Tomas, Meeusen, Els N., de Veer, Michael, Morton, David A. V., Kaminskas, Lisa M. and McIntosh, Michelle P. (2011). New developments in dry powder pulmonary vaccine delivery. Trends in Biotechnology, 29 (4), 191-198. doi: 10.1016/j.tibtech.2010.12.009

New developments in dry powder pulmonary vaccine delivery

2011

Journal Article

Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated pegylated polylysine dendrimers

Kaminskas, Lisa M., Kelly, Brian D., McLeod, Victoria M., Sberna, Gian, Boyd, Ben J., Owen, David J. and Porter, Christopher J. H. (2011). Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated pegylated polylysine dendrimers. Molecular Pharmaceutics, 8 (2), 338-349. doi: 10.1021/mp1001872

Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated pegylated polylysine dendrimers

2009

Journal Article

PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats

Kaminskas, Lisa M., Kota, Jagannath, McLeod, Victoria M., Kelly, Brian D., Karellas, Peter and Porter, Christopher J. H. (2009). PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats. Journal of Controlled Release, 140 (2), 108-116. doi: 10.1016/j.jconrel.2009.08.005

PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats

2009

Journal Article

Partly-PEGylated poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers

Kaminskas, L. M., Wu, Z., Barlow, N., Krippner, G. Y., Boyd, B. J. and Porter, C. J. H. (2009). Partly-PEGylated poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers. Journal of Pharmaceutical Sciences, 98 (10), 3871-3875. doi: 10.1002/jps.21692

Partly-PEGylated poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers

2009

Journal Article

Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-L-lysine dendrimers

Kaminskas, Lisa M., Kelly, Brian D., McLeod, Victoria M., Boyd, Ben J., Krippner, Guy Y., Williams, Elizabeth D. and Porter, Christopher J. H. (2009). Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-L-lysine dendrimers. Molecular Pharmaceutics, 6 (4), 1190-1204. doi: 10.1021/mp900049a

Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-L-lysine dendrimers

2008

Journal Article

The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of pegylated poly L-lysine dendrimers

Kaminskas, Lisa M., Boyd, Ben J., Karellas, Peter, Krippner, Guy Y., Lessene, Romina, Kelly, Brian and Porter, Chrisiopher J. H. (2008). The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of pegylated poly L-lysine dendrimers. Molecular Pharmaceutics, 5 (3), 449-463. doi: 10.1021/mp7001208

The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of pegylated poly L-lysine dendrimers

2008

Journal Article

Carbonyl-scavenging drugs & protection against carbonyl stress-associated cell injury

Burcham, P. C., Kaminskas, L. M., Tan, D. and Pyke, S. M. (2008). Carbonyl-scavenging drugs & protection against carbonyl stress-associated cell injury. Mini-Reviews in Medicinal Chemistry, 8 (4), 319-330. doi: 10.2174/138955708783955953

Carbonyl-scavenging drugs & protection against carbonyl stress-associated cell injury

2007

Journal Article

Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and disposition

Kaminskas, Lisa M., Boyd, Ben J., Karellas, Peter, Henderson, Scott A., Giannis, Michael P., Krippner, Guy Y. and Porter, Christopher J. H. (2007). Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and disposition. Molecular Pharmaceutics, 4 (6), 949-961. doi: 10.1021/mp070047s

Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and disposition

2007

Journal Article

Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugs

Kaminskas, Lisa M., Pyke, Simon M. and Burcham, Philip C. (2007). Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugs. Rapid Communications in Mass Spectrometry, 21 (7), 1155-1164. doi: 10.1002/rcm.2945

Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugs

2006

Journal Article

Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats

Boyd, Ben J., Kaminskas, Lisa M., Karellas, Peter, Krippner, Guy, Lessene, Romina and Porter, Christopher J. H. (2006). Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats. Molecular Pharmaceutics, 3 (5), 614-627. doi: 10.1021/mp060032e

Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats

2005

Journal Article

Differences in lysine adduction by acrolein and methyl vinyl ketone: implications for cytotoxicity in cultured hepatocytes

Kaminskas, Lisa M., Pyke, Simon M. and Burcham, Philip C. (2005). Differences in lysine adduction by acrolein and methyl vinyl ketone: implications for cytotoxicity in cultured hepatocytes. Chemical Research in Toxicology, 18 (11), 1627-1633. doi: 10.1021/tx0502387

Differences in lysine adduction by acrolein and methyl vinyl ketone: implications for cytotoxicity in cultured hepatocytes

2004

Journal Article

Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde

Kaminskas, Lisa M., Pyke, Simon M. and Burcham, Philip C. (2004). Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde. Organic and Biomolecular Chemistry, 2 (18), 2578-2584. doi: 10.1039/b408796h

Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde

2004

Journal Article

Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice

Kaminskas, Lisa M., Pyke, Simon M. and Burcham, Philip C. (2004). Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice. Journal of Pharmacology and Experimental Therapeutics, 310 (3), 1003-1010. doi: 10.1124/jpet.104.067330

Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice

2004

Journal Article

Protein Adduct-Trapping by Hydrazinophthalazine Drugs: Mechanisms of Cytoprotection Against Acrolein-Mediated Toxicity

Burcham, Philip C., Fontaine, Frank R., Kaminskas, Lisa M., Petersen, Dennis R. and Pyke, Simon M. (2004). Protein Adduct-Trapping by Hydrazinophthalazine Drugs: Mechanisms of Cytoprotection Against Acrolein-Mediated Toxicity. Molecular Pharmacology, 65 (3), 655-664. doi: 10.1124/mol.65.3.655

Protein Adduct-Trapping by Hydrazinophthalazine Drugs: Mechanisms of Cytoprotection Against Acrolein-Mediated Toxicity

2002

Journal Article

Aldehyde-Sequestering Drugs: Tools for Studying Protein Damage by Lipid Peroxidation Products

Burcham, Philip C., Kaminskas, Lisa M., Fontaine, Frank R., Petersen, Dennis R. and Pyke, Simon M. (2002). Aldehyde-Sequestering Drugs: Tools for Studying Protein Damage by Lipid Peroxidation Products. Toxicology, 181-182, 229-236. doi: 10.1016/S0300-483X(02)00287-1

Aldehyde-Sequestering Drugs: Tools for Studying Protein Damage by Lipid Peroxidation Products

2002

Journal Article

The contribution of the metabolitep-hydroxyamphetamine to the central actions ofp-methoxyamphetamine

Kaminskas, Lisa M., Irvine, Rodney J., Callaghan, Paul D., White, Jason M. and Kirkbride, Paul (2002). The contribution of the metabolitep-hydroxyamphetamine to the central actions ofp-methoxyamphetamine. Psychopharmacology, 160 (2), 155-160. doi: 10.1007/s00213-001-0984-z

The contribution of the metabolitep-hydroxyamphetamine to the central actions ofp-methoxyamphetamine

2000

Journal Article

Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions

Gamble, Jennifer R., Drew, Jenny, Trezise, Libby, Underwood, Anne, Parsons, Michelle, Kasminkas, Lisa, Rudge, John, Yancopoulos, George and Vadas, Mathew A. (2000). Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circulation research, 87 (7), 603-607. doi: 10.1161/01.res.87.7.603

Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions

Current funding

  • 2024 - 2028
    Nanoparticle gene therapy for cystic fibrosis
    NHMRC MRFF PPHR - Chronic Respiratory Conditions
    Open grant

Past funding

  • 2020 - 2021
    UQ AWARE - Dr Lisa Kaminskas
    UQ Amplify Women's Academic Research Equity
    Open grant
  • 2019 - 2021
    A/Prof Lisa Kaminskas - AQ WRAP
    Advance Queensland Women's Research Assistance Program
    Open grant
  • 2019 - 2023
    Understanding the kinetics of nanomedicine clearance from healthy and diseased lungs
    NHMRC Project Grant
    Open grant
  • 2019
    Advanced Brightfield and Fluorescent High Speed and Throughput Slide Scanner for biological, medical, materials science, and agricultural applications
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019
    Vevo 3100 Imaging System for ultrahigh resolution and frame rate echocardiographic assessment of small animals.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2017 - 2018
    Investigation of the Pharmacokinetics of Avalyn Pharma's Compound in Sheep
    UniQuest Pty Ltd
    Open grant
  • 2017 - 2018
    A Pharmacology Screening Facility to Accelerate Drug Discovery and Development
    UQ Major Equipment and Infrastructure
    Open grant
  • 2017 - 2019
    Designing Nanoparticles to Combat Cellular Dysfunction (ARC Discovery Grant administered by Monash University)
    Monash University
    Open grant
  • 2016 - 2020
    Improving cancer survival by optimising drug exposure at sites of cancer metastasis
    NHMRC Career Development Fellowship
    Open grant
  • 2016
    Optimising the therapeutic efficacy of protein-based drugs against lymph-resident diseases.
    NHMRC Project Grant
    Open grant

Availability

Associate Professor Lisa Kaminskas is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Associate Professor Lisa Kaminskas directly for media enquiries about:

  • cancer drug delivery
  • lung drug delivery
  • lymphatic system drug delivery
  • nanomedicine

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au